Clinical Trial Update: Feasibility of Lecanemab Registry and Clinical Outcome Measures

View source ↗

Summary

Feasibility study assessing a lecanemab patient registry and the planned clinical outcome measures for Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: HealthPartners Institute | Conditions: Alzheimer Disease | Status: ENROLLING_BY_INVITATION